Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,538,108
+$1,226,033 QoQ
Shares Held
26,926
+7.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#229
of 772 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $26,666,840 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
123,571 | $5,070,118 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
26,926 | $4,538,108 | |
| 3 | HLN |
Haleon plc
|
478,177 | $4,461,391 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,176 | $2,262,682 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
110,838 | $1,776,733 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
15,254 | $1,692,278 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
52,791 | $1,299,186 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
17,775 | $1,136,711 |
All Filings in NBIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,538,108 | 26,926 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,312,075 | 25,141 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,207,954 | 29,669 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,306,437 | 30,677 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,015,041 | 31,944 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $3,043,490 | 27,518 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $3,535,759 | 25,903 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $3,103,335 | 26,934 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $3,738,428 | 27,155 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | $3,994,852 | 28,965 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | $3,880,990 | 29,455 | Shares | Sole | 2025-07-31 | |
| 2023-09-30 | $3,622,950 | 32,204 | Shares | Sole | 2025-07-31 | |
| 2023-06-30 | $2,660,297 | 28,211 | Shares | Sole | 2025-07-31 | |
| 2023-03-31 | $3,215,759 | 31,770 | Shares | Sole | 2025-07-31 | |
| 2022-12-31 | $3,926,231 | 32,872 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $3,734,343 | 35,160 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $3,272,696 | 33,573 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $3,138,187 | 33,474 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,302,996 | 27,040 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,056,363 | 31,867 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,101,296 | 31,867 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,077,335 | 11,078 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,268,299 | 54,964 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,441,021 | 25,385 | Shares | Sole | 2020-12-03 | |
| No filing history on record for this holder in this stock. | ||||||